✦ LIBER ✦

Beyond EGFR TKI in EGFR-mutant Non-Small Cell Lung Cancer patients: Main challenges still to be overcome

✍ Scribed by Remon, J.; Morán, T.; Reguart, N.; Majem, M.; Carcereny, E.; Lianes, P.

Book ID: 121677357
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 525 KB
Volume: 40
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2014.03.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of EGFR-TKI induced cell deat

Mechanisms of EGFR-TKI induced cell death and resistance in EGFR mutant non-small cell lung cancer

✍ J. Ko; Y. Kim; M. Park; Z. Cui; M. Ahn; K. Park 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Clinical Characteristics of EGFR-TKI–Ind

Clinical Characteristics of EGFR-TKI–Induced Interstitial Pneumonitis in Korean Non–Small-Cell Lung Cancer Patients

✍ In-Jae Oh; Song Choi; Yong-Soo Kwon; Kyu-Sik Kim; Yu-Il Kim; Sung-Chul Lim; Youn 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 42 KB

Impact of specific mutant KRAS on clinic

Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype

✍ Metro, Giulio; Chiari, Rita; Duranti, Simona; Siggillino, Annamaria; Fischer, Ma 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 568 KB

A diagnostic algorithm using EGFR mutati

A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer

✍ Kawahara, Akihiko; Taira, Tomoki; Azuma, Koichi; Tominaga, Masaki; Hattori, Sato 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 641 KB

Primary resistance to epidermal growth f

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

✍ Lee, J. K.; Shin, J.- Y.; Kim, S.; Lee, S.; Park, C.; Kim, J.- Y.; Koh, Y.; Keam 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 215 KB

Reaction of plasma hepatocyte growth fac

Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs

✍ Hidenori Tanaka; Tatsuo Kimura; Shinzoh Kudoh; Shigeki Mitsuoka; Tetsuya Watanab 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 242 KB

## Abstract Hepatocyte growth factor induces resistance to epidermal growth factor receptor tyrosine kinase inhibitors. It has been hypothesized that epidermal growth factor receptor tyrosine kinase inhibitors administration may influence the levels of plasma hepatocyte growth factor. Patients with